AU2001261343A1 - Method of regulating angiogenesis using ryk protein - Google Patents

Method of regulating angiogenesis using ryk protein

Info

Publication number: AU2001261343A1
Authority: AU; Australia
Prior art keywords: regulating angiogenesis; ryk protein; ryk; protein; angiogenesis
Prior art date: 2000-05-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001261343A

Inventor

Nathalie A. Dubois-Stringfellow

Steve Roczniak

Alya Zolotorev

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer Corp

Original Assignee

Bayer AG

Bayer Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-10

Filing date

2001-05-09

Publication date

2001-11-20

2001-05-09 Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG

2001-11-20 Publication of AU2001261343A1 publication Critical patent/AU2001261343A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Ophthalmology & Optometry (AREA)
Biophysics (AREA)
Heart & Thoracic Surgery (AREA)
Oncology (AREA)
Dermatology (AREA)
Cell Biology (AREA)
Immunology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Cardiology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Enzymes And Modification Thereof (AREA)

AU2001261343A 2000-05-10 2001-05-09 Method of regulating angiogenesis using ryk protein Abandoned AU2001261343A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US56878300A	2000-05-10	2000-05-10
US09568783		2000-05-10
PCT/US2001/015043 WO2001085789A2 (en)	2000-05-10	2001-05-09	Extracellular domain of ryk protein for regulating angiogenesis

Publications (1)

Publication Number	Publication Date
AU2001261343A1 true AU2001261343A1 (en)	2001-11-20

Family

ID=24272718

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001261343A Abandoned AU2001261343A1 (en)	2000-05-10	2001-05-09	Method of regulating angiogenesis using ryk protein

Country Status (13)

Country	Link
EP (1)	EP1287121A2 (en)
JP (1)	JP2004527206A (en)
AR (1)	AR028424A1 (en)
AU (1)	AU2001261343A1 (en)
CA (1)	CA2408349A1 (en)
CO (1)	CO5300464A1 (en)
DO (1)	DOP2001000164A (en)
EC (1)	ECSP014068A (en)
GT (1)	GT200100079A (en)
PE (1)	PE20011218A1 (en)
SV (1)	SV2002000442A (en)
UY (1)	UY26696A1 (en)
WO (1)	WO2001085789A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1471934A2 (en) *	2002-02-06	2004-11-03	DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung	Kinases involved in the regulation of energy homeostasis
JO3283B1 (en)	2011-04-26	2018-09-16	Sanofi Sa	Composition including Afflipersept, Folinic Acid, 5- Fluorouracil (5- Fu) and Irenosetan (FOLFIRI)
MX375557B (en)	2014-07-18	2025-03-06	Sanofi Sa	Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer
JP2024535691A (en) *	2021-08-18	2024-10-02	ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア	Anti-receptor tyrosine kinase-related protein (Ryk) antibodies and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0646129A4 (en) *	1992-05-11	1995-07-19	Ludwig Inst Cancer Res	RECEPTOR-TYPE TYROSINE KINASE-LIKE MOLECULES.
EP0854185A3 (en) *	1994-12-23	1998-10-21	Ludwig Institute For Cancer Research	Assay receptor proteins and ligands
WO1999064589A1 (en) *	1998-06-11	1999-12-16	Astrazeneca Ab	Human receptor tyrosine kinase
ATE406907T1 (en) *	1998-10-28	2008-09-15	Cornell Res Foundation Inc	METHODS FOR REGULATION OF ANGIOGENESIS AND VASCULAR INTEGRITY USING TRK RECEPTOR LIGANDS BDNF, NT-3 AND NT-4

2001
- 2001-05-07 AR ARP010102149A patent/AR028424A1/en not_active Application Discontinuation
- 2001-05-07 GT GT200100079A patent/GT200100079A/en unknown
- 2001-05-08 UY UY26696A patent/UY26696A1/en not_active Application Discontinuation
- 2001-05-09 EP EP01935233A patent/EP1287121A2/en not_active Withdrawn
- 2001-05-09 CO CO01036462A patent/CO5300464A1/en unknown
- 2001-05-09 EC EC2001004068A patent/ECSP014068A/en unknown
- 2001-05-09 JP JP2001582388A patent/JP2004527206A/en active Pending
- 2001-05-09 CA CA002408349A patent/CA2408349A1/en not_active Abandoned
- 2001-05-09 SV SV2001000442A patent/SV2002000442A/en not_active Application Discontinuation
- 2001-05-09 WO PCT/US2001/015043 patent/WO2001085789A2/en not_active Ceased
- 2001-05-09 AU AU2001261343A patent/AU2001261343A1/en not_active Abandoned
- 2001-05-10 DO DO2001000164A patent/DOP2001000164A/en unknown
- 2001-05-10 PE PE2001000417A patent/PE20011218A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2408349A1 (en)	2001-11-15
DOP2001000164A (en)	2002-05-15
AR028424A1 (en)	2003-05-07
CO5300464A1 (en)	2003-07-31
JP2004527206A (en)	2004-09-09
SV2002000442A (en)	2002-07-03
WO2001085789A3 (en)	2002-05-16
EP1287121A2 (en)	2003-03-05
WO2001085789A2 (en)	2001-11-15
ECSP014068A (en)	2002-02-25
UY26696A1 (en)	2001-12-28
PE20011218A1 (en)	2002-02-01
GT200100079A (en)	2001-12-31

Publication	Publication Date	Title
AU2002362197A1 (en)	2003-07-24	Method of stabilizing protein
AU2001232799A1 (en)	2001-08-20	Protein c derivatives
AU2001240115A1 (en)	2001-09-24	Method for the preparation of tetrahydrobenzothiepines
AU2001231085A1 (en)	2001-09-24	Method of making protein arrays
AU2001280201A1 (en)	2002-06-20	Methods of synthesizing cell-free protein
AU2001236005A1 (en)	2001-09-12	Preparations stabilized over long time
AU2002216431A1 (en)	2002-06-18	Method for expression of proteins on spore surface
AU2001241075A1 (en)	2001-11-29	Method of anticipating interaction between proteins
AU2002306918A1 (en)	2002-10-08	Methods of modulating angiogenesis
AU2001295450A1 (en)	2002-02-18	Method of polypeptide renaturation
AU2001280588A1 (en)	2002-01-30	Methods of modulating angiogenesis
AU2001241771A1 (en)	2001-09-12	Use of avocado-soybean unsaponifiable preparations
AU2002361763A1 (en)	2003-06-30	Method of reducing angiogenesis
AU2001261343A1 (en)	2001-11-20	Method of regulating angiogenesis using ryk protein
AU2001269077A1 (en)	2002-01-02	Methods and means for regulation of gene expression
AU2002354363A1 (en)	2003-06-17	Method of activating protein
AU2001274080A1 (en)	2001-12-11	Regulation of human transketolase-like enzyme
AU2002231620A1 (en)	2002-05-15	Regulation of human patched-like protein
AU2001293780A1 (en)	2002-03-13	Regulation of human protein phosphatase iic-like enzyme
AU2001269095A1 (en)	2002-01-08	Regulation of human caspase-1-like protease
AU5647101A (en)	2001-11-20	Over expression of the whn protein
AU2002215942A1 (en)	2002-04-22	Regulation of human carboxylesterase-like enzyme
AU2001281969A1 (en)	2002-01-30	Regulation of human carboxylesterase-like enzyme
AU2002237225A1 (en)	2002-06-18	Regulation of human patched-like protein
AU2002215721A1 (en)	2002-06-18	Method of cloning animals